What is the current Price Target for the Eagle Pharmaceuticals, Inc. stock?

The average Eagle Pharmaceuticals, Inc. target price is $17.34. This is 1,056.00% higher than the current stock price. The highest price target is 1,090.00%, the lowest is 1,044.67%. 3 Analysts have issued a price target Eagle Pharmaceuticals, Inc. 2026 .

How high will the Eagle Pharmaceuticals, Inc. stock rise?

No reliable answer can be given as to how high the Eagle Pharmaceuticals, Inc. stock will rise. The performance of stocks, including the Eagle Pharmaceuticals, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Eagle Pharmaceuticals, Inc. stock today?

The performance of Eagle Pharmaceuticals, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Eagle Pharmaceuticals, Inc. stock fall?

The decline in Eagle Pharmaceuticals, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Eagle Pharmaceuticals, Inc. Forecast, price target & analysts

$1.50

97.37% yesterday

Nasdaq, Nov 07, 03:30 pm CET

ISIN

US2697961082

Symbol

EGRX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Eagle Pharmaceuticals, Inc. Target price 2025 - Analyst rating & recommendation

Eagle Pharmaceuticals, Inc. Classifications & Recommendation:

Buy

86%

Hold

14%

Eagle Pharmaceuticals, Inc. Price Target

Target Price	$17.34
Price	$1.50
Potential	1,056.00% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Eagle Pharmaceuticals, Inc. 2026 . The average Eagle Pharmaceuticals, Inc. target price is $17.34. This is 1,056.00% register free of charge higher than the current stock price. The highest price target is $17.85 1,090.00% register free of charge , the lowest is $17.17 1,044.67% register free of charge .
	A rating was issued by 7 analysts: 6 Analysts recommend Eagle Pharmaceuticals, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Eagle Pharmaceuticals, Inc. stock has an average upside potential 2026 of 1,056.00% register free of charge . Most analysts recommend the Eagle Pharmaceuticals, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2023, 2024 & 2025

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '22	2023 Estimates
Earnings Per Share $	2.73	4.67
	513.64%	71.06%
P/E		0.16
EV/Sales		0.25

Based on analysts' sales estimates for 2023, the Eagle Pharmaceuticals, Inc. stock is valued at an EV/Sales of

Unlock

and an P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	0.25	4.17%
2023	0.25 1.84% Unlock
2024	0.30 22.17% Unlock
2025	0.28 5.60% Unlock

Current	0.04	38.27%
2023	0.04 2.09% Unlock
2024	0.05 22.13% Unlock
2025	0.04 5.68% Unlock

Eagle Pharmaceuticals, Inc....

Discover more stocks with a high price target

Novo Nordisk 60.25%

TUI 59.01%

Adidas 53.11%

Deutsche Telekom 45.39%

Meta Platforms (Facebook) 43.56%

Adyen 39.97%

BYD 38.89%

BioNTech SE - ADR 34.99%

Coinbase Global, Inc. 33.30%

Infineon 30.91%

Microsoft 29.34%

Netflix 28.46%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now